• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » J&J touts perioperative efficiency CareAdvantage study data

J&J touts perioperative efficiency CareAdvantage study data

October 5, 2017 By Fink Densford

Johnson & Johnson's CareAdvantage

Johnson & Johnson (NYSE:JNJ) this week reported results from a real-world evidence study of its CareAdvantage program, touting improved tray set up time and reduced surgical tray numbers with an estimated $262,000 saved annually.

The data was presented at the Academic Orthopaedic Consortium’s annual meeting yesterday, the company said.

“An important priority for UCSF as an academic institution is optimizing our OR processes and delivering better care to our patients. The study results provide insights about how we can achieve our goals by reducing the variation in clinical processes, lowering our inventory costs and physical footprint, improving our clinical staff’s productivity, reducing environmental impact, and helping enhance quality of care,” UCSF orthopedic surgery dept. chief administrative officer Richard Capra said in a prepared statement.

The study aimed to examine improvements in surgical instrument tray set-up time, as well as several other endpoints, for total knee and hip procedures using J&J’s CareAdvantage.

Results from the trial indicated a 3 minute reduction in tray set up time for hip procedures and 6 minute reduction for knee procedures, as well as a 57% reduction in the total number of surgical instrument trays and a 29% decrease in the number of instruments used across both types of procedures. J&J also reported a 46% reduction in the average number of open trays.

Total savings was estimated to be more than $262,000 annually, Johnson & Johnson reports.

“Approaches such as the one used by JJMDC and UCSF can help hospitals and health systems make important strides in addressing perioperative management. As both academic institutions and other systems seek how to deliver efficiencies and better outcomes, improving the processes involved in performing surgical operations can be a critical area to make an impact,” Academic Orthopaedic Consortium founder Michael Gagnon said in a prepared release.

Johnson & Johnson said that results from a recent US health systems survey indicated that 64% of executives and 56% of clinicians are seeking strategies to increase perioperative efficiency.

“Perioperative efficiency is an important area of focus for health systems seeking to improve clinical processes, lower operational costs and enhance patient outcomes. Our CareAdvantage approach starts with listening and focuses on leveraging data to identify goals and create actionable plans for improvement for health systems to achieve value-based care,” J&J MDC health economics and market access VP Dr. Christina Farup said in a press release.

In August, J&J touted its CareAdvantage supply chain services, saying it helped Spectrum Health and its 12-hospital system cut weekly out-of-stock devices by nearly 50%, reduced expedited shipping fees and the number of days products are out of stock.

Filed Under: Clinical Trials, Hospital Care, Orthopedics Tagged With: Johnson and Johnson

More recent news

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • Ancora Heart reaches enrollment milestone in pivotal heart failure device trial
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Johnson & Johnson launches daily disposable multifocal toric contact lens
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy